XML 29 R16.htm IDEA: XBRL DOCUMENT
v3.20.4

Fair Value Measurements | 6 Months Ended
--- | ---
Jan. 02, 2021
Fair Value Disclosures [Abstract] |
Fair Value Measurements | Note 8. Fair Value Measurements Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. There is an established hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. Observable inputs are, inputs which market participants would use in valuing an asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs which reflect the assumptions market participants would use in valuing an asset or liability. The three levels of inputs that may be used to measure fair value are as follows: •Level 1: includes financial instruments for which quoted market prices for identical instruments are available in active markets. Level 1 assets of the Company include money market funds, U.S. Treasury securities and marketable equity securities as they are traded with sufficient volume and frequency of transactions. •Level 2: includes financial instruments for which the valuations are based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. Level 2 instruments of the Company generally include certain U.S. and foreign government and agency securities, commercial paper, corporate and municipal bonds and notes, asset-backed securities, certificates of deposit, and foreign currency forward contracts. To estimate their fair value, the Company utilizes pricing models based on market data. The significant inputs for the valuation model usually include benchmark yields, reported trades, broker and dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data, and industry and economic events. •Level 3: includes financial instruments for which fair value is derived from valuation-based inputs, that are unobservable and significant to the overall fair value measurement. As of January 2, 2021 and June 27, 2020, the Company did not hold any Level 3 investment securities. The fair value of the Company’s contingent liabilities was determined using Level 3 inputs. The Company’s Level 3 liabilities as of January 2, 2021, consist of contingent purchase consideration related to its business and asset acquisitions completed during fiscal 2020 and 2019. The fair value of earn-out liabilities was determined using a Monte Carlo Simulation that includes significant unobservable inputs such as the risk-adjusted discount rate, gross profit volatility, and projected financial forecast of acquired business over the earn-out period. The fair value of contingent consideration liabilities is remeasured at each reporting period at the estimated fair value based on the inputs on the date of remeasurement, with the change in fair value recognized in the Selling, General and Administrative expense of the Consolidated Statements of Operations. Fair Value Measurements The Company’s assets and liabilities measured at fair value (categorized by input measure) for the periods presented are as follows (in millions):
| January 2, 2021 |  | June 27, 2020
| Total |  | Level 1 |  | Level 2 |  | Level 3 |  | Total |  | Level 1 |  | Level 2 |  | Level 3
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Debt available-for-sale securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Asset-backed securities | $ | 0.5 |  |  | $ | — |  |  | $ | 0.5 |  |  | $ | — |  |  | $ | 0.5 |  |  | $ | — |  |  | $ | 0.5 |  |  | $ | — |
Total debt available-for-sale securities | 0.5 |  |  | — |  |  | 0.5 |  |  | — |  |  | 0.5 |  |  | — |  |  | 0.5 |  |  | — |
Money market funds | 387.2 |  |  | 387.2 |  |  | — |  |  | — |  |  | 334.6 |  |  | 334.6 |  |  | — |  |  | — |
Trading securities | 1.6 |  |  | 1.6 |  |  | — |  |  | — |  |  | 1.4 |  |  | 1.4 |  |  | — |  |  | — |
Foreign currency forward contracts (1) | 8.4 |  |  | — |  |  | 8.4 |  |  | — |  |  | 2.2 |  |  | — |  |  | 2.2 |  |  | — |
Total assets (2) | $ | 397.7 |  |  | $ | 388.8 |  |  | $ | 8.9 |  |  | $ | — |  |  | $ | 338.7 |  |  | $ | 336.0 |  |  | $ | 2.7 |  |  | $ | — |
Liability: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency forward contracts (3) | $ | 1.5 |  |  | $ | — |  |  | $ | 1.5 |  |  | $ | — |  |  | $ | 1.5 |  |  | $ | — |  |  | $ | 1.5 |  |  | $ | — |
Contingent consideration (4) | 8.9 |  |  | — |  |  | — |  |  | 8.9 |  |  | 9.9 |  |  | — |  |  | — |  |  | 9.9 |
Total liabilities | $ | 10.4 |  |  | $ | — |  |  | $ | 1.5 |  |  | $ | 8.9 |  |  | $ | 11.4 |  |  | $ | — |  |  | $ | 1.5 |  |  | $ | 9.9 |
(1)$8.4 million and $2.2 million in prepayments and other current assets on the Company’s Consolidated Balance Sheets as of January 2, 2021 and June 27, 2020, respectively. (2)Includes as of January 2, 2021, $379.6 million in cash and cash equivalents, $1.6 million in short-term investments, $3.0 million in restricted cash, $8.4 million in prepayments and other current assets and $5.1 million in other non-current assets on the Company’s Consolidated Balance Sheets. Includes as of June 27, 2020, $327.2 million in cash and cash equivalents, $1.4 million in short-term investments, $3.4 million in restricted cash, $2.2 million in prepayments and other current assets, and $4.5 million in other non-current assets on the Company’s Consolidated Balance Sheets. (3)Includes $1.5 million and $1.5 million in other current liabilities on the Company’s Consolidated Balance Sheets as of January 2, 2021 and June 27, 2020, respectively. (4)Includes $6.9 million and $9.4 million in other non-current liabilities and $2.0 million and $0.5 million in other current liabilities as of January 2, 2021 and June 27, 2020, respectively. The following table provides a reconciliation of changes in the fair value of the Company’s Level 3, contingent consideration liabilities, for the three and six months ended January 2, 2021 (in millions):
|  | Three Months Ended |  | Six Months Ended
|  | January 2, 2021 |  | December 28, 2019 |  | January 2, 2021 |  | December 28, 2019
Beginning period balance |  | $ | 9.9 |  |  | $ | 40.1 |  |  | $ | 9.9 |  |  | $ | 38.4 |
Fair value adjustment of contingent consideration liabilities |  | (1.5) |  |  | (6.0) |  |  | (1.5) |  |  | (4.3) |
Currency translation adjustment |  | 0.5 |  |  | — |  |  | 0.5 |  |  | — |
Balance as of October 3, 2020 |  | $ | 8.9 |  |  | $ | 34.1 |  |  | $ | 8.9 |  |  | $ | 34.1 |
No payments were made in connection with the Company’s contingent earn-out liabilities during the three and six months ended January 2, 2021 and December 28, 2019.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration